Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single ascending dose study of RO5428029 in healthy male volunteers
NL-OMON34361Phase 1Active, not recruiting
- Sponsor
- Roche
- Start
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of RO5428029 in hepatitis C virus infection, sponsored by Roche. Started Sep 2010; status: active, not recruiting.
02
Drugs
RO5428029
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on NL-OMON34361.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON34361.